Ovarian Cancer News

CancerConnect ovarian cancer news, tips, and features provide breaking research stories, helpful tips, and inspiring features related to ovarian cancer. The unique daily cancer news service evaluates all aspects of ovarian cancer research and reports on the developments that are most important to cancer patients and healthcare providers, while the tips and features offer insight into all aspects of ovarian cancer treatment and survivorship.

Share

Ovarian Cancer News


Avastin Plus Chemotherapy Improves Progression-Free Survival in Platinum-Resistant Recurrent Ovarian Cancer (April 9, 2014)

The addition of Avastin® (bevacizumab) to standard chemotherapy significantly improved progression-free survival and objective response rate among women with platinum-resistant recurrent ovarian cancer,... Continue Reading

Aspirin as Ovarian Cancer Prevention? Research Says Maybe (February 20, 2014)

New evidence suggests that an aspirin a day may reduce the risk of ovarian cancer. But more research is needed before your doctor will routinely prescribe it for prevention. You may know that low doses... Continue Reading

Dacogen Helps Recurrent Ovarian Cancer Respond to Vaccine (January 30, 2014)

Treatment with Dacogen® (decitabine) prior to the administration of Adriamycin® (doxorubicin) and a cancer vaccine yielded clinical benefit for women with recurrent ovarian cancer, according to a study... Continue Reading

Marriage May Have a Protective Effect for Cancer Patients (December 17, 2013)

Social support may have a significant impact on cancer detection, treatment, and survival, according to the results of a study published in the Journal of Clinical Oncology. The study showed that married... Continue Reading

Oral Contraceptives and the Risk of Breast and Ovarian Cancer (November 20, 2013)

Women with BRCA 1/2 mutations who use oral contraceptives (birth control pills) have a significantly reduced risk of ovarian cancer and a non-significantly increased risk of breast cancer, according to... Continue Reading

The Highlights: Advances in Screening and Management of Ovarian Cancer (November 7, 2013)

News from annual meetings of the Society of Gynecologic Oncology and the American Society of Clinical Oncology By Krishnansu S. Tewari, MD, FACOG, FACS Society of Gynecologic Oncology The 44th Annual Meeting... Continue Reading

Cediranib Improves Survival in Recurrent Ovarian Cancer (October 21, 2013)

Women with recurrent ovarian cancer experienced significantly improved survival when they received targeted agent cediranib with chemotherapy and as maintenance therapy after chemotherapy, according to... Continue Reading

Summary News on Melanoma, Breast, Cervical, Ovarian, Prostate and Thyroid Cancer from Amer Soc Clinical Oncology Annual Meeting (October 1, 2013)

By Kari Bohlke, ScD Annual meeting brings together cancer experts from around the world. For thousands of oncology professionals and cancer researchers from around the world, the Annual Meeting of the... Continue Reading

Dose-Dense Paclitaxel Plus Carboplatin Improves Long-Term Survival in Advanced Ovarian Cancer (September 18, 2013)

Dose-dense paclitaxel plus carboplatin was associated with significantly improved progression-free and overall survival compared with conventional paclitaxel/carboplatin as first-line treatment in patients... Continue Reading

Live Web Chat on “The Latest in Ovarian Cancer Treatment,” featuring Dana-Farber/Brigham and Women’s Cancer Center Expert (September 17, 2013)

On September 17th Dana-Farber/Brigham and Women’s Cancer Center gynecologic oncology expert, Ursula A. Matulonis, MD, presented an overview of the latest in ovarian cancer treatment and answered questions... Continue Reading

More Ovarian Cancer News

Latest Ovarian Cancer News By Stage


Screening and Prevention

Aspirin as Ovarian Cancer Prevention? Research Says Maybe (February 20, 2014)

New evidence suggests that an aspirin a day may reduce the risk of ovarian cancer. But more research is needed before your doctor will routinely prescribe it for prevention. You may know that low doses of aspirin, taken daily, can help reduce the risk... Continue Reading

Oral Contraceptives and the Risk of Breast and Ovarian Cancer (November 20, 2013)

Women with BRCA 1/2 mutations who use oral contraceptives (birth control pills) have a significantly reduced risk of ovarian cancer and a non-significantly increased risk of breast cancer, according to the results of a study published in the Journal of... Continue Reading

Live Web Chat on “The Latest in Ovarian Cancer Treatment,” featuring Dana-Farber/Brigham and Women’s Cancer Center Expert (September 17, 2013)

On September 17th Dana-Farber/Brigham and Women’s Cancer Center gynecologic oncology expert, Ursula A. Matulonis, MD, presented an overview of the latest in ovarian cancer treatment and answered questions during a live Web chat. Dr. Matulonis is the... Continue Reading

Ovarian Cancer Rates Appeared to Drop Along with a Drop in the Use of Hormone Replacement Therapy (June 21, 2013)

Ovarian rates began to decline faster in 2002, which is about the same time many older women stopped using hormone replacement therapy, according to the results of a study published in the Journal of Clinical Oncology. Hormone replacement therapy (HRT)... Continue Reading

Ovarian Cancer Rates Declining in Breast Cancer Survivors (February 7, 2013)

The rate of second primary ovarian cancers after first primary breast cancer appears to be on the decline, according to the results of a study published in the Journal of Clinical Oncology. Each year in the United States, roughly 22,000 women are diagnosed... Continue Reading

More Screening and Prevention

Stage I

Aspirin as Ovarian Cancer Prevention? Research Says Maybe (February 20, 2014)

New evidence suggests that an aspirin a day may reduce the risk of ovarian cancer. But more research is needed before your doctor will routinely prescribe it for prevention. You may know that low doses of aspirin, taken daily, can help reduce the risk... Continue Reading

Live Web Chat on “The Latest in Ovarian Cancer Treatment,” featuring Dana-Farber/Brigham and Women’s Cancer Center Expert (September 17, 2013)

On September 17th Dana-Farber/Brigham and Women’s Cancer Center gynecologic oncology expert, Ursula A. Matulonis, MD, presented an overview of the latest in ovarian cancer treatment and answered questions during a live Web chat. Dr. Matulonis is the... Continue Reading

Ovarian Cancer Rates Declining in Breast Cancer Survivors (February 7, 2013)

The rate of second primary ovarian cancers after first primary breast cancer appears to be on the decline, according to the results of a study published in the Journal of Clinical Oncology. Each year in the United States, roughly 22,000 women are diagnosed... Continue Reading

Diabetes Drug May Help Prevent or Treat Ovarian Cancer (December 3, 2012)

Metformin, a widely prescribed insulin-lowering drug for diabetes, has been associated with survival in ovarian cancer and is worthy of further study, as it may be considered for the prevention or treatment of ovarian cancer, according to the results... Continue Reading

Treatment at High-Volume Hospitals Leads to Lower Mortality Rates for Ovarian Patients (November 20, 2012)

Ovarian cancer patients who undergo surgery at high-volume hospitals have better outcomes than those who are treated at low-volume hospitals, according to the results of a study published in the Journal of Clinical Oncology. This is the result not of... Continue Reading

More Stage I

Stages II-IV

Aspirin as Ovarian Cancer Prevention? Research Says Maybe (February 20, 2014)

New evidence suggests that an aspirin a day may reduce the risk of ovarian cancer. But more research is needed before your doctor will routinely prescribe it for prevention. You may know that low doses of aspirin, taken daily, can help reduce the risk... Continue Reading

Dacogen Helps Recurrent Ovarian Cancer Respond to Vaccine (January 30, 2014)

Treatment with Dacogen® (decitabine) prior to the administration of Adriamycin® (doxorubicin) and a cancer vaccine yielded clinical benefit for women with recurrent ovarian cancer, according to a study published in Cancer Immunology Research. Ovarian... Continue Reading

Dose-Dense Paclitaxel Plus Carboplatin Improves Long-Term Survival in Advanced Ovarian Cancer (September 18, 2013)

Dose-dense paclitaxel plus carboplatin was associated with significantly improved progression-free and overall survival compared with conventional paclitaxel/carboplatin as first-line treatment in patients with advanced ovarian cancer, according to the... Continue Reading

Live Web Chat on “The Latest in Ovarian Cancer Treatment,” featuring Dana-Farber/Brigham and Women’s Cancer Center Expert (September 17, 2013)

On September 17th Dana-Farber/Brigham and Women’s Cancer Center gynecologic oncology expert, Ursula A. Matulonis, MD, presented an overview of the latest in ovarian cancer treatment and answered questions during a live Web chat. Dr. Matulonis is the... Continue Reading

Maintenance Therapy with Votrient Provides Benefit in Advanced Ovarian Cancer (June 13, 2013)

In a Phase III clinical trial, treatment with Votrient® (pazopanib) after initial chemotherapy improved outcomes among women with advanced ovarian cancer. These results were presented at the 2013 Annual Meeting of the American Society of Clinical Oncology... Continue Reading

More Stages II-IV

Recurrent

Avastin Plus Chemotherapy Improves Progression-Free Survival in Platinum-Resistant Recurrent Ovarian Cancer (April 9, 2014)

The addition of Avastin® (bevacizumab) to standard chemotherapy significantly improved progression-free survival and objective response rate among women with platinum-resistant recurrent ovarian cancer, according to the results of a study published early... Continue Reading

Aspirin as Ovarian Cancer Prevention? Research Says Maybe (February 20, 2014)

New evidence suggests that an aspirin a day may reduce the risk of ovarian cancer. But more research is needed before your doctor will routinely prescribe it for prevention. You may know that low doses of aspirin, taken daily, can help reduce the risk... Continue Reading

Dacogen Helps Recurrent Ovarian Cancer Respond to Vaccine (January 30, 2014)

Treatment with Dacogen® (decitabine) prior to the administration of Adriamycin® (doxorubicin) and a cancer vaccine yielded clinical benefit for women with recurrent ovarian cancer, according to a study published in Cancer Immunology Research. Ovarian... Continue Reading

Cediranib Improves Survival in Recurrent Ovarian Cancer (October 21, 2013)

Women with recurrent ovarian cancer experienced significantly improved survival when they received targeted agent cediranib with chemotherapy and as maintenance therapy after chemotherapy, according to the results of a study presented at the ESMO 2013... Continue Reading

Live Web Chat on “The Latest in Ovarian Cancer Treatment,” featuring Dana-Farber/Brigham and Women’s Cancer Center Expert (September 17, 2013)

On September 17th Dana-Farber/Brigham and Women’s Cancer Center gynecologic oncology expert, Ursula A. Matulonis, MD, presented an overview of the latest in ovarian cancer treatment and answered questions during a live Web chat. Dr. Matulonis is the... Continue Reading

More Recurrent

CancerConnect Cancer Commuity & Discussions


Cancer Types

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Just another WordPress weblog
Facebook Twitter RSS